CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Formaat: Artigo
Taal:Russo
Gepubliceerd in: IRBIS LLC 2016-02-01
Reeks:Фармакоэкономика
Onderwerpen:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Online toegang:https://www.pharmacoeconomics.ru/jour/article/view/130
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items